IP Library Granted Patent US 8,753,884
Granted Patent B2
US 8,753,884 · App. 12/152,779 · Granted Jun 17, 2014

Method of differentiation of morula or inner cell mass cells and method of making lineage-defective embryonic stem cells

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,753,884
App. No.
12/152,779
Granted
Jun 17, 2014
Kind
B2
Abstract

An improved method of producing differentiated progenitor cells comprising obtaining inner cell mass cells from a blastocyst and inducing differentiation of the inner cell mass cells to produce differentiated progenitor cells. The differentiated progenitor cells may be transfected such that there is an addition, deletion or alteration of a desired gene. The differentiated progenitor cells are useful in cell therapy and as a I source of cells for the production of tissues and organs for transplantation. Also provided is a method of producing a lineage-defective human embryonic stem cell.

Claims (29)

1. A method of producing differentiated cells, comprising:

i) obtaining morula cells or inner cell mass cells from a human blastocyst by mechanical and/or enzymatic means; and

ii) inducing the morula cells or inner cell mass cells to differentiate directly into differentiated cells, wherein the inducing step comprises a) addition of a differentiating agent directly to the morula cells or inner cell mass cells or b) placement of the morula cells or inner cell mass cells directly in a differentiation environment chosen from a flat adhesive environment, a microgravity environment and a 3D adhesive environment; and

iii) isolating the differentiated cells from ii), thereby producing differentiated cells.

2. The method according to claim 1 , wherein said blastocyst is produced by in vitro fertilization.

3. The method according to claim 1 , wherein said blastocyst is produced from a nuclear transfer unit.

4. The method according to claim 3 , wherein a desired DNA is inserted, removed or modified in said nuclear transfer unit, thereby resulting in the production of a genetically altered differentiated cell.

5. The method according to claim 1 , wherein said morula cells or inner cell mass cells are induced to differentiate in a flat adhesive environment.

6. The method according to claim 1 , wherein said morula cells or inner cell mass cells are induced to differentiate in a 3D adhesive environment.

7. The method according to claim 1 , wherein said morula cells or inner cell mass cells are induced to differentiate in a microgravity.

8. A method of producing differentiated cells, comprising:

i) obtaining morula cells or inner cell mass cells from a human blastocyst by mechanical and/or enzymatic means; and

ii) inducing the morula cells or inner cell mass cells to differentiate directly into differentiated cells, wherein the inducing step comprises a) addition of a differentiating agent directly to the morula cells or inner cell mass cells or b) placement of the morula cells or inner cell mass cells directly in a differentiation environment wherein the morula or inner cell mass cells are induced to differentiate by generation of teratomas in immunodeficient mice; and

iii) isolating the differentiated cells from ii), thereby producing differentiated cells.

9. The method according to claim 1 , wherein the differentiated cells are differentiated progenitor cells.

10. The method according to claim 9 , wherein the differentiated progenitor cells give rise to mesoderm.

11. The method according to claim 9 , wherein the differentiated progenitor cells give rise to ectoderm.

12. The method according to claim 9 , wherein the differentiated progenitor cells give rise to endoderm.

13. A method of producing differentiated cells, the method comprising:

i) obtaining morula cells or inner cell mass cells from a human blastocyst by mechanical and/or enzymatic means; and

ii) inducing the morula cells or inner cell mass cells to differentiate directly into differentiated cells, wherein the inducing step consists of a) addition of a differentiating agent directly to the morula cells or inner cell mass cells or b) placement of the morula cells or inner cell mass cells directly in a differentiation environment chosen from a flat adhesive environment, a microgravity environment, and a 3D adhesive environment, thereby producing

differentiated cells.

14. A method of producing differentiated cells, the method consisting of;

i) obtaining morula cells or inner cell mass cells from a human blastocyst by mechanical and/or enzymatic means; and

ii) inducing the morula cells or inner cell mass cells to differentiate directly into differentiated cells, wherein the inducing step consists of a) addition of a differentiating agent directly to the morula cells or inner cell mass cells or b) placement of the morula cells or inner cell mass cells directly in a differentiation environment chosen from a flat adhesive environment, a microgravity environment and a 3D adhesive environment; and

iii) isolating the differentiated cells from ii), thereby producing differentiated cells.

15. A method comprising:

i) obtaining morula cells or inner cell mass cells from a human blastocyst by mechanical and/or enzymatic means; and

ii) contacting the obtained morula cells or inner cell mass cells with a differentiating agent.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Nov 24, 2014
From: CAMOFI MASTER LDC; CAMHZN MASTER LDC
To: ADVANCED CELL TECHNOLOGY, INC.; MYTOGEN, INC.
Reel/Frame 034421/0863 →
SECURITY AGREEMENT Recorded Jan 25, 2013
From: ADVANCED CELL TECHNOLOGY, INC.; MYTOGEN, INC.
To: CAMOFI MASTER LDC; CAMHZN MASTER LDC
Reel/Frame 029698/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 26, 2012
From: CIBELLI, JOSE; WEST, MICHAEL D.; LANZA, ROBERT P.
To: ADVANCED CELL TECHNOLOGY
Reel/Frame 029528/0850 →